These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A prospective study of leukocyte telomere length and risk of renal cell carcinoma. Hofmann JN; Lan Q; Cawthon R; Hosgood HD; Shuch B; Moore LE; Rothman N; Chow WH; Purdue MP Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):997-1000. PubMed ID: 23513041 [TBL] [Abstract][Full Text] [Related]
3. Leukocyte telomere length and Morais M; Dias F; Resende T; Nogueira I; Oliveira J; Maurício J; Teixeira AL; Medeiros R Future Oncol; 2020 Jun; 16(18):1245-1255. PubMed ID: 32422075 [No Abstract] [Full Text] [Related]
4. Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer. Yang M; Prescott J; Poole EM; Rice MS; Kubzansky LD; Idahl A; Lundin E; De Vivo I; Tworoger SS Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):339-345. PubMed ID: 28209595 [No Abstract] [Full Text] [Related]
5. Long leukocyte telomere length in prostate cancer patients at diagnosis is associated with poor metastasis-free and cancer-specific survival. Svenson U; Roos G; Wikström P Tumour Biol; 2017 Feb; 39(2):1010428317692236. PubMed ID: 28222672 [TBL] [Abstract][Full Text] [Related]
6. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma. Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570 [TBL] [Abstract][Full Text] [Related]
7. Telomere length in peripheral leukocytes is associated with immune cell tumor infiltration and prognosis in colorectal cancer patients. Svenson U; Öberg Å; Stenling R; Palmqvist R; Roos G Tumour Biol; 2016 Aug; 37(8):10877-82. PubMed ID: 26883253 [TBL] [Abstract][Full Text] [Related]
8. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). Sturgeon SR; Pilsner JR; Arcaro KF; Ikuma K; Wu H; Kim SM; Chopra-Tandon N; Karpf AR; Ziegler RG; Schairer C; Balasubramanian R; Reckhow DA Breast Cancer Res; 2017 Aug; 19(1):94. PubMed ID: 28821281 [TBL] [Abstract][Full Text] [Related]
9. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer. Julin B; Shui I; Heaphy CM; Joshu CE; Meeker AK; Giovannucci E; De Vivo I; Platz EA Br J Cancer; 2015 Feb; 112(4):769-76. PubMed ID: 25562437 [TBL] [Abstract][Full Text] [Related]
10. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. Lotan Y; Karam JA; Shariat SF; Gupta A; Roupret M; Bensalah K; Margulis V Urol Oncol; 2016 Apr; 34(4):167.e9-16. PubMed ID: 26602092 [TBL] [Abstract][Full Text] [Related]
11. Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Seow WJ; Cawthon RM; Purdue MP; Hu W; Gao YT; Huang WY; Weinstein SJ; Ji BT; Virtamo J; Hosgood HD; Bassig BA; Shu XO; Cai Q; Xiang YB; Min S; Chow WH; Berndt SI; Kim C; Lim U; Albanes D; Caporaso NE; Chanock S; Zheng W; Rothman N; Lan Q Cancer Res; 2014 Aug; 74(15):4090-8. PubMed ID: 24853549 [TBL] [Abstract][Full Text] [Related]
12. LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk. Karami S; Andreotti G; Liao LM; Pfeiffer RM; Weinstein SJ; Purdue MP; Hofmann JN; Albanes D; Mannisto S; Moore LE Epigenetics; 2015; 10(4):282-92. PubMed ID: 25647181 [TBL] [Abstract][Full Text] [Related]
13. Leukocyte Telomere Length and All-Cause, Cardiovascular Disease, and Cancer Mortality: Results From Individual-Participant-Data Meta-Analysis of 2 Large Prospective Cohort Studies. Mons U; Müezzinler A; Schöttker B; Dieffenbach AK; Butterbach K; Schick M; Peasey A; De Vivo I; Trichopoulou A; Boffetta P; Brenner H Am J Epidemiol; 2017 Jun; 185(12):1317-1326. PubMed ID: 28459963 [TBL] [Abstract][Full Text] [Related]
15. Plasma vitamin D biomarkers and leukocyte telomere length in men. Julin B; Shui IM; Prescott J; Giovannucci EL; De Vivo I Eur J Nutr; 2017 Mar; 56(2):501-508. PubMed ID: 26558766 [TBL] [Abstract][Full Text] [Related]
16. U-Shaped Relationship of Leukocyte Telomere Length With All-Cause and Cancer-Related Mortality in Older Men. Yeap BB; Hui J; Knuiman MW; Flicker L; Divitini ML; Arscott GM; Twigg SM; Almeida OP; Hankey GJ; Golledge J; Norman PE; Beilby JP J Gerontol A Biol Sci Med Sci; 2021 Jan; 76(1):164-171. PubMed ID: 32761187 [TBL] [Abstract][Full Text] [Related]
17. Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese. Ko JM; Tsang KH; Dai W; Choi SSA; Leong MM; Ngan RK; Kwong DL; Cheng A; Lee AW; Ng WT; Tung S; Lee VH; Lam KO; Chan CK; Lung ML Int J Cancer; 2018 Nov; 143(9):2289-2298. PubMed ID: 29873071 [TBL] [Abstract][Full Text] [Related]
18. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis. Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691 [TBL] [Abstract][Full Text] [Related]
19. Circulating Prostate-Specific Antigen and Telomere Length in a Nationally Representative Sample of Men Without History of Prostate Cancer. Wulaningsih W; Astuti Y; Matsuguchi T; Anggrandariyanny P; Watkins J; Prostate; 2017 Jan; 77(1):22-32. PubMed ID: 27566127 [TBL] [Abstract][Full Text] [Related]
20. Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study. Dugué PA; Bassett JK; Wong EM; Joo JE; Li S; Yu C; Schmidt DF; Makalic E; Doo NW; Buchanan DD; Hodge AM; English DR; Hopper JL; Giles GG; Southey MC; Milne RL JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]